skip to content
Stories
Careers
About Roche
About Roche
Strategy
Business
Sustainability
Leadership
Governance
History
Solutions
Solutions
Focus areas
Pharma solutions
Diagnostic solutions
Pipeline
Innovation
Innovation
Team & structure
Innovation process
Ethical standards
Partnering
Investors
Investors
Investor updates
Investor events
Reporting
Finance Information Tool
Share and Bond information
Download center
Media
Media
Media releases
Media events
Media statements
Media library
worldwide
About Roche
explore
Strategy
Business
Sustainability
Leadership
Governance
History
Solutions
explore
Focus areas
Pharma solutions
Diagnostic solutions
Pipeline
Innovation
explore
Team & structure
Innovation process
Ethical standards
Partnering
Investors
explore
Investor updates
Investor events
Reporting
Finance Information Tool
Share and Bond information
Download center
Media
explore
Media releases
Media events
Media statements
Media library
Stories
Careers
Roche Venture Fund
Roche Venture Fund News Archive
News archive
COUR Pharmaceuticals Secures $105 Million in Series A Financing
January 30, 2024
RVF participates in Mironid's Funding Round
September 13, 2023
DiogenX raises EUR27.5M Series A financing
May 10, 2023
Germany-based company acquires lino Biotech
March 16, 2023
Enliven Therapeutics Closes Merger with Imara and Private Placement of USD161 Million
February 23, 2023
Bionano Genomics to Acquire Purigen Biosystems
November 28, 2022
Bonum Therapeutics Announces a $93M Series Financing to Advance a Novel and Validated Class of Conditionally Active Therapies
November 15, 2022
Roche acquires Good Therapeutics to complement next generation PD1-IL2 therapeutics
September 7, 2022
Jasper Therapeutics Closes Transaction With Amplitude Healthcare Creating a Publicly Traded Biotechnology Company
April 21, 2022
Roche Venture Fund invests in the seed financing of Thelium Therapeutics
April 19, 2022
GlycoEra AG announced today the close of a CHF 45 million ($49 million) Series A financing round
November 5, 2021
Entrada Therapeutics Announces Closing of Initial Public Offering
November 2, 2021
Jasper Therapeutics Closes Transaction With Amplitude Healthcare Creating a Publicly Traded Biotechnology Company
September 24, 2021
Tango Therapeutics, Inc.closes merger with BCTG Acquisition Corp
August 10, 2021
Tempest Closes Merger with Millendo and Completes PIPE Financing
June 28, 2021
23andMe Successfully Closes its Business Combination with VG Acquisition Corp.
June 16, 2021
Centessa Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
June 4, 2021
Soteria Biotherapeutics launches with USD42 Million Series A Financing led by Roche Venture Fund and 5AM Ventures
May 17, 2021
Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Merger to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation
May 6, 2021
Eloxx Pharmaceuticals Acquires Zikani Therapeutics
April 1, 2021
Merck Completes Acquisition of Pandion Therapeutics
April 1, 2021
Tempest and Millendo Announce Proposed Merger Agreement
March 29, 2021
Enthera Pharmaceuticals extends Series A financing, raising a total of €35 million
January 28, 2021
Enliven Therapeutics Launches With Vision Of Advancing Medicine And Restoring Lives
December 7, 2020
Aligos Therapeutics announces Pricing of Initial Public Offering
October 15, 2020
C4 Therapeutics announces Pricing of an Upsized Initial Public Offering
October 1, 2020
Palladio Biosciences completes USD20 Million Series B Financing
September 25, 2020
BCTG Acquisition Corp. Announces Pricing of Upsized $145 Million Initial Public Offering
September 3, 2020
Vaxcyte Announces Pricing of Upsized Initial Public Offering
June 11, 2020
Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use
May 22, 2020
Jasper Therapeutics Announces Expansion of Series A Financing, Bringing Total Corporate Fundraising to More than $50 Million
January 9, 2020
Roche enters licensing agreement with Sarepta Therapeutics to improve the lives of patients living with Duchenne muscular dystrophy
December 23, 2019
Black Diamond Therapeutics Closes $85 Million Series C Financing
December 5, 2019
Purigen Biosystems Raises $26.4 Million Series B Financing to Accelerate Commercialization of Automated Sample Preparation Platform
November 11, 2019
NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapies to Treat Rare Diseases
October 1, 2019
Allakos Announces AK002 Met All Prespecified Primary and Secondary Endpoints in Phase 2 Randomized, Double-Blind, Placebo-Controlled Study in Patients with Eosinophilic Gastritis (EG) and/or Eosinophilic Gastroenteritis (EGE)
August 5, 2019
Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detection
July 24, 2019
IDEAYA Announces Pricing of Initial Public Offering
May 22, 2019
Arch Oncology Raises $50 Million Series B Financing
March 25, 2019
Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics
March 20, 2019
Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform
December 18, 2018
Allakos announces Pricing of Initial Public Offering
July 19, 2018
Roche joins Intel & iSeed as investors in Care Innovations to expand its integrated diabetes management solutions with mySugr
June 25, 018
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing. Inkef Capital and Roche Venture Fund join investor syndicate
March 23, 2018
IDEAYA Biosciences Raises $94 Million Crossover Series B Financing
March 15, 2018
Pandion Therapeutics Announces $58 Million Series A Financing to Advance Tissue-Specific Immune Modulator Drugs for Autoimmune and Inflammatory Diseases
January 18, 2018
Syapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in Oncology
January 9, 2018
mySugr joins the Roche Family
July 30, 2017
Aileron Therapeutics Announces Pricing of Initial Public Offering
June 29, 2017
Senseonics Announces Pricing of $41 Million Underwritten Offering of Common Stock
May 26, 2017
Vivet Therapeutics raises €37.5 million in Series A financing round to advance novel gene therapies for treating inherited metabolic diseases
May 4, 2017
CiVi Biopharma Receives Worldwide Exclusive License to Develop a Novel, RNA Targeted Drug Against PCSK-9
January 5, 2017
Tioma Therapeutics Announces $86 Million Series A Financing
August 16, 2016
Viewics Secures $10.5 Million in Capital, Closes Funding to Bring Advanced Analytics to Healthcare
August 3, 2016
Omicia Raises $23 Million in Series B Funding
June 8, 2016
Purigen Biosystems Receives $18.2M in Series A Financing led by 5AM Ventures and Roche Venture Fund
May 17, 2016
Second Genome Secures $42.6 Million in Series B Financing Led by Pfizer Venture Investments and Roche Venture Fund
April 20, 2016
Lumos Pharma raises $34 million in Series B financing
April 6, 2016
:quality(90)/)